CD4 and nonpapillary renal cell carcinoma: Considering that both HHLA2 and PD-L1 belong to the B7 family and both have an inhibitory function on CD4+ or CD8+ T cells, we attempted to explore the prognostic impact of HHLA2/PD-L1 co-expression in ccRCC.